<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Division of Psychiatry</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/28D1D01E-DF6A-4AAE-9BDF-0E1013164105"><gtr:id>28D1D01E-DF6A-4AAE-9BDF-0E1013164105</gtr:id><gtr:firstName>Hugh Malcolm</gtr:firstName><gtr:surname>Gurling</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701007"><gtr:id>E54A4C9B-4AFF-4BFE-AA03-A6C65D6E328E</gtr:id><gtr:title>MOLECULAR GENETICS OF BIPOLAR AFFECTIVE DISORDER</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701007</gtr:grantReference><gtr:abstractText>Bipolar disorder and certain types of severe depression run in families and are strongly genetic. Genetic research can therefore identify DNA changes that cause susceptibility to these mental illnesses. Genetic linkage studies of families have identified which chromosomes the genes for these types of depression are localised on. However, new technology borrowed from the microelectronics industry has enabled the University Collele London research group and their USA collaborators to rapidly identify at least thirty nine new genes likely to be causing genetic susceptibility to depression. We now wish to develop this research by identifying the precise genetic abnormalities in these genes that increase susceptibility to bipolar disorder. Abnormalities that are found will be studied for their clinical effects and their role in the variability of psychiatric symptoms and responsiveness to drug treatments. The identification of pathways involved in disease susceptibility should lead to the creation of new treatments and prevention strategies for bipolar and other types of affective disorders.</gtr:abstractText><gtr:technicalSummary>The applicants have carried out a family based genome wide linkage study of bipolar disorder and more recently a genome wide association study with [Lambert, 2005 #1245]single nucleotide polymorphisms in the UCL Bipolar case control sample. After comparison with genome wide association tests in an independent sample from our USA collaborators we have identified thirty eight new affective disorder susceptibility genes. It is now proposed that we resequence DNA from the top twenty most significantly associated genes in those UCL bipolar cases contributing to the positive allelic associations. This will enable potential aetiological base pair changes for affective disorders to be detected. Once these DNA changes have been found this will form a solid scientific foundation for studies of clinical phenotype and treatment response variation, as well as studies of gene expression, protein interaction, animal models and new drug design based on valid protein targets. With the proposed MRC support we propose to select the one or two of the 20 genes sequenced that is most strongly implicated in terms of new aetiological base pair changes and to carry out in depth gene expression, protein interaction and animal model studies over the five year period.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>456286</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>MRC Technology Agreement</gtr:description><gtr:id>1B88609B-0F08-4E19-B5DC-505CA21DD0A9</gtr:id><gtr:impact>The publication: Yan, T.C. et al. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD. J Psychopharmacol (2009). Describes the mouse model of ADHD/Bipolar disorder and also the human genetic finding in ADHD. The UCL based human genetic finding of association between TACR1 and bipolar disorder has been published twice. These papers are: Sklar, P. et al. Whole-genome association study of bipolar disorder. Mol Psychiatry 13, 558-569 (2008). Ferreira, M.A. et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40, 1056-8 (2008).</gtr:impact><gtr:outcomeId>C201D596A2E-1</gtr:outcomeId><gtr:partnerContribution>I have been working with Dr Clare Stanford and Professor Stephen Hunt also at UCL on what can broadly be described as a pharmacogenomic project. Genetic involvement of the TACR1 (neurokinin 1 receptor) gene in susceptibility to ADHD and bipolar disorder was shown by my lab. and others and this has meant that a new small molecule has been synthesised by MRCT which has very high affinity to NK1R/TACR1. Clare Stanford is now testing this drug which is a NK1R agonist in normal and TACR1 homozygous hypomorphic mouse. The drug could be used to treat mania in bipolar disorder and overactivity in ADHD</gtr:partnerContribution><gtr:piContribution>My lab. linked the TACR1 gene to ADHD and bipolar disorder in UCL based sample and has been searching then searching for mutations and aetiological base pair changes which can cause the molecular pathology of a subtype of bipolar disorder and ADHD. We have also shown that TACR1 has a role in genetic susceptibility to alcoholism which could also be targeted with new drug treatments to treat alcoholism.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NIH Psychiatric Genetics GWAS consortium</gtr:description><gtr:id>F459C5D1-46A1-428A-96CE-F4ABFC900824</gtr:id><gtr:impact>Multidisciplinary research. Sklar, P., Smoller, J.W., Fan, J., Ferreira, M.A., Perlis, R.H., Chambert, K., Nimgaonkar, V.L., McQueen, M.B., Faraone, S.V., Kirby, A., de Bakker, P.I., Ogdie, M.N., Thase, M.E., Sachs, G.S., Todd-Brown, K., Gabriel, S.B., Sougnez, C., Gates, C., Blumenstiel, B., Defelice, M., Ardlie, K.G., Franklin, J., Muir, W.J., McGhee, K.A., MacIntyre, D.J., McLean, A., VanBeck, M., McQuillin, A., Bass, N.J., Robinson, M., Lawrence, J., Anjorin, A., Curtis, D., Scolnick, E.M., Daly, M.J., Blackwood, D.H., Gurling, H.M. &amp;amp; Purcell, S.M. Mol Psychiatry 13, 558-69 (2008).</gtr:impact><gtr:outcomeId>2F900AAFE28-1</gtr:outcomeId><gtr:partnerContribution>Large data set</gtr:partnerContribution><gtr:piContribution>Clinical and genetic data to large consortium</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Showcase</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2D30A54E-4C83-45CC-AED4-A3267D94EF79</gtr:id><gtr:impact>I presented evidence of genes and thier proteins which could be targeted with new drugs. The TACR1 gene was mentioned as being genetically involved in bipolar disorder.

A further grant application for genetically based drug discovery is being prepared</gtr:impact><gtr:outcomeId>19E4A956B38</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>365000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stanley Medical Research Institute (SMRI), USA Grant</gtr:description><gtr:end>2012-07-02</gtr:end><gtr:fundingOrg>Stanley Medical Research Institute (SMRI)</gtr:fundingOrg><gtr:id>2C4B96F4-32F7-418C-8265-1B74965B2F21</gtr:id><gtr:outcomeId>6BD02AB8BF10</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>019AE01C-FD2A-41F8-8201-C73B02F3D619</gtr:id><gtr:outcomeId>9EA603343FE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>All disorders that could be related to molecular pathology of the TACR1/NK1R gene and receptor protein have been cited in a patent for diagnostic testing in the DNA of patients with these disorders. In addition the mouse model has been licensed to Cerebricon for use in drug development for ADHD.</gtr:description><gtr:grantRef>G0701007</gtr:grantRef><gtr:id>003D6BC1-61AD-479D-8A7D-A0FA9CB97C69</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>FE4E73DDC6D</gtr:outcomeId><gtr:patentId>WO2004040016</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Genetic prediction of ADHD and Bipolar disorder at the TACR1/NK1R gene locus.</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>New genetic effect in ADHD and bipolar disorder as diagnostic test and new treatment approach to these disorders</gtr:description><gtr:grantRef>G0701007</gtr:grantRef><gtr:id>38844DA1-7334-43B7-88D6-C04FDEEEA207</gtr:id><gtr:impact>New drug synthesised by MRC drug development unit at NIMR Mill Hill</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BC32F9D3F42</gtr:outcomeId><gtr:patentId>WO2009130465</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>NK1R (TACR1) gene in bipolar affective disorder and ADHD</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Samples of DNA which are derived from cases of bipolar disorder and ADHD who have inherited a genetic susceptibility from the TACR1 gene causing their disorder.</gtr:description><gtr:id>D1C08460-2287-43D5-BDD0-FC1919F1AABE</gtr:id><gtr:impact>Drug development and the ability identify patients who could respond to specific treatments.</gtr:impact><gtr:outcomeId>24ABA7581A7</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Genetic aetiology of ADHD and bipolar disorder</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>DNA and Clinical Phenotype data</gtr:description><gtr:id>85A57BE9-FBB4-4E4B-8EC9-D6F65CFBD4FE</gtr:id><gtr:impact>See publications listed elsewhere in this report</gtr:impact><gtr:outcomeId>316266991F5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bipolar case control sample</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Microarray genetic data</gtr:description><gtr:id>48A6258E-930A-4488-8A2F-4507E657DA00</gtr:id><gtr:impact>New understanding of biological factors in bipolar affective disorder</gtr:impact><gtr:outcomeId>446990503CE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genotype and clincal data on bipolar disorder</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F5DA2A6A-85F5-4588-B0BB-B77FA5F66CE2</gtr:id><gtr:title>NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/775c89ca0c00e5c0bd0c88cfcc94558f"><gtr:id>775c89ca0c00e5c0bd0c88cfcc94558f</gtr:id><gtr:otherNames>Yan TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>2019A5B8EE3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF6D46FD-821F-4BA9-B00A-C290F7FA9CDD</gtr:id><gtr:title>Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>5675dce9eba24</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3C44D23-996B-417B-AD81-2E9BA9B626E9</gtr:id><gtr:title>CACNA1C hypermethylation is associated with bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Translational psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e047dba5f5c4cb37e17b40d7fdb9acbc"><gtr:id>e047dba5f5c4cb37e17b40d7fdb9acbc</gtr:id><gtr:otherNames>Starnawska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2158-3188</gtr:issn><gtr:outcomeId>585d65c0a1a648.97882118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9E7FE90-E410-40EC-985F-FCBA8E474616</gtr:id><gtr:title>DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd00b5751b792945e70ee187e8553402"><gtr:id>cd00b5751b792945e70ee187e8553402</gtr:id><gtr:otherNames>Hennah W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>5B22F943001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CAA84B2-C945-4CBC-A83A-BA5374CBA11E</gtr:id><gtr:title>Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>ULk4ZCBA8Ap</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78E5EA15-2F43-4E5B-B79C-3F618578F2F8</gtr:id><gtr:title>Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia.</gtr:title><gtr:parentPublicationTitle>Behavioral and brain functions : BBF</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89ab98ebc38fe55186f1fc18366901cd"><gtr:id>89ab98ebc38fe55186f1fc18366901cd</gtr:id><gtr:otherNames>Bass NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1744-9081</gtr:issn><gtr:outcomeId>8B1F2E2732D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21A29548-FA12-4F9D-BEB5-C312F8EF29AD</gtr:id><gtr:title>Genetic variant analysis of the putative regulatory regions of the LRRC7 gene in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>585d65c43b7551.54190523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8837CD9-24E0-4ED2-8E93-E7BA34A8A7C7</gtr:id><gtr:title>Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f93f82efad719587546ad13494eaffa"><gtr:id>8f93f82efad719587546ad13494eaffa</gtr:id><gtr:otherNames>Ingason A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>mnAvL6W2BCz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C131293-EBD1-4634-B952-BBFA60F0BB92</gtr:id><gtr:title>Genetics of attention-deficit hyperactivity disorder (ADHD).</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02c18e63f80f85ded789fda5d6a3e178"><gtr:id>02c18e63f80f85ded789fda5d6a3e178</gtr:id><gtr:otherNames>Sharp SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>AF63DCA1CAB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0591B12B-DE8B-4EA7-A254-30E28BF09281</gtr:id><gtr:title>Sequencing of the ANKYRIN 3 gene (ANK3) encoding ankyrin G in bipolar disorder reveals a non-conservative amino acid change in a short isoform of ankyrin G.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fac5f345b8b7382d8f43aa0a84d9af8"><gtr:id>4fac5f345b8b7382d8f43aa0a84d9af8</gtr:id><gtr:otherNames>Dedman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_15137_27_22328486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BB73BB2-8EF2-4AC2-B941-3B48AB8AACBE</gtr:id><gtr:title>The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e08eef1083248fa868790100035444d0"><gtr:id>e08eef1083248fa868790100035444d0</gtr:id><gtr:otherNames>O'Brien NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>doi_55faa1aa1cf7b31c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A0DF665-685C-42D3-9BEB-F93A4C6F7075</gtr:id><gtr:title>European collaborative study of early-onset bipolar disorder: Evidence for genetic heterogeneity on 2q14 according to age at onset.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ced1f61a6a7e9f071280e33c16a3c67"><gtr:id>5ced1f61a6a7e9f071280e33c16a3c67</gtr:id><gtr:otherNames>Mathieu F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>aZenzr2vTCD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A088946D-3EBB-40B6-A730-F4C59326CDE2</gtr:id><gtr:title>Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>doi_55faa1aa1d00dd1b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC58DB70-83D0-465A-A457-44DCF2CAF8F0</gtr:id><gtr:title>Genetic variation in the miR-708 gene and its binding targets in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d990ef14e535b425800fed62133764af"><gtr:id>d990ef14e535b425800fed62133764af</gtr:id><gtr:otherNames>Fiorentino A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>585d3906438251.06052036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A225E869-5E13-4769-B02F-64ED9761628D</gtr:id><gtr:title>Exome sequence analysis and follow up genotyping implicates rare ULK1 variants to be involved in susceptibility to schizophrenia.</gtr:title><gtr:parentPublicationTitle>Annals of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fda2100b1b5abff7e5c09c078192c784"><gtr:id>fda2100b1b5abff7e5c09c078192c784</gtr:id><gtr:otherNames>Al Eissa MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0003-4800</gtr:issn><gtr:outcomeId>5a2fd75a47c327.42144523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8517C6E7-3AB4-48B0-AFAF-7B55C8E7292D</gtr:id><gtr:title>Association study of rare nonsynonymous variants of FTO in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Psychiatric genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1758c3916b6d5bb1c70f8da4d201940c"><gtr:id>1758c3916b6d5bb1c70f8da4d201940c</gtr:id><gtr:otherNames>Curtis JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0955-8829</gtr:issn><gtr:outcomeId>585d50002d4217.32646628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01F2F1E1-821D-4541-A08C-B819C4BD35FC</gtr:id><gtr:title>Hypomethylation of FAM63B in bipolar disorder patients.</gtr:title><gtr:parentPublicationTitle>Clinical epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e047dba5f5c4cb37e17b40d7fdb9acbc"><gtr:id>e047dba5f5c4cb37e17b40d7fdb9acbc</gtr:id><gtr:otherNames>Starnawska A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1868-7075</gtr:issn><gtr:outcomeId>585d5018840018.08964267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B74F3336-F9F3-4ACE-9B78-04F7D56D7B3C</gtr:id><gtr:title>Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02c18e63f80f85ded789fda5d6a3e178"><gtr:id>02c18e63f80f85ded789fda5d6a3e178</gtr:id><gtr:otherNames>Sharp SI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>pm_540e141e1417c1456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54485F1B-C799-4E95-8C02-33EDBABFE116</gtr:id><gtr:title>Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e06716f8e1a6a5996d09b885aae9cd2f"><gtr:id>e06716f8e1a6a5996d09b885aae9cd2f</gtr:id><gtr:otherNames>Psychiatric GWAS Consortium Bipolar Disorder Working Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>AKX2SbXgstX</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701007</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>